Philips launches EXIT-CVD project. Philips stock heads into the next Xetra session at EUR 23.04
Published on 10/18/2026 at 17:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResearch timeline and trading setup
- Royal Philips announced the EXIT-CVD project on October 15, 2026, covering 22 clinical studies.
- Philips stock enters the next Xetra session at EUR 23.04 after the October 16, 2026, Xetra close.
- The consortium includes 42 partners across 17 countries, with first patient enrollment planned for October 2026.
Royal Philips announced the five-year EXIT-CVD cardiovascular research project on October 15, 2026, according to the Yahoo Finance report. The project includes 22 clinical studies involving more than 14,000 patients.
Market context: Market report AEX.
The week in figures
The Xetra-listed Philips instrument closed at EUR 23.04 on October 16, 2026. A weekly high, weekly low and weekly percentage balance are not stated here because the available dated quote does not establish those figures.
Chronology of the week
On October 15, 2026, Royal Philips announced EXIT-CVD, a five-year project co-led with University Medical Center Groningen. The consortium brings together 42 public and private partners across 17 countries, according to the Yahoo Finance report.
Dates of the coming week
The project announcement says that first patients will be enrolled in October 2026. The 22 clinical studies are intended to cover cardiovascular detection, monitoring and treatment across Europe, according to the Yahoo Finance report.
Weekend trading
The next price is shown from the start of trading by the continuously updated real-time quote of Philips stock.
